Health Care / Hospitals News and Press Releases

Health Care / Hospitals

Releases published in the last 30 days.

Page 1 of 3

Vali Health Raises $6M to Build Responsible AI Infrastructure for Home Care Agencies: 6/17/2026 9:35:05 AM; Vali Health, a startup building responsible AI infrastructure for the home care industry, today emerged from stealth with $6 million in funding from Bonfire Ventures, Supernode, Comma Capital, along with Jacquelyn Kung, an industry veteran who built two of the largest software platforms for home care.
“Beyond Feet on Fire,” Best-Selling Book Offered for Free (Ending Soon) (Until 6/19/26): 6/17/2026 6:00:00 AM; Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” It will be available in the Amazon store for free for two more days.
A tiny ingestible sensor can measure temperature from inside the body: 6/16/2026 8:00:21 AM; In a hospital or at home, temperatures are usually taken using an oral or forehead thermometer, but these do not always accurately reflect the core body temperature.
ATA Action Bringing Top Federal Policy Priorities to Capitol Hill to Support Permanent Access to Virtual Care and Digital Health Tools: 6/16/2026 7:29:55 AM; ATA Action, the affiliated policy and legislative advocacy arm of the American Telemedicine Association, met with 35 Congressional offices, House and Senate leadership offices, and key committee leaders during its 4 th annual Hill Day on June 10, to advance federal policies that support permanent access to telehealth and digital health tools and encourage innovation in …
Alicia Baca Rush’s “The Good Kind of Cancer” To Be Displayed at a Book Festival at Printers Row, Chicago: 6/15/2026 8:58:30 PM; Alicia Baca Rush’s book, “The Good Kind of Cancer: Turning Pain Into Purpose — One Day At A Time — A Health Memòria,” will be showcased by the self-publishing and book marketing company ReadersMagnet at an upcoming book festival at Printers Row in Chicago.
Heartseed Announces First Patient Dosed in a Phase I/II EMERALD Study with HS-005 – a Cell Therapy Administered via Catheter, Designed to Restore Heart Function in People with Severe Heart Failure: 6/15/2026 12:16:05 PM; Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation (Nikon), manufactures iPSC-derived purified cardiomyocyte spheroids of HS-005, under contract to Heartseed Inc.(Heartseed).
New tool for measuring synbiotic synergy potential could shape the next wave of food and drink innovation supporting gut health: 6/15/2026 11:00:42 AM; Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, welcomes the publication of a new peer-reviewed study from world-leading APC Microbiome Ireland at University College Cork, supported in part by research grants from Tate & Lyle and Research Ireland.
CONV2X Announces Smart Technology Transformation in Healthcare & Life Sciences Summit in New York City: 6/15/2026 10:56:45 AM; CONV2X Smart Technology Transformation in Healthcare & Life Sciences, announced its annual two-day executive summit taking place October 29–30, 2026 at the Historic GE Building, ILR Conference Center, 570 Lexington Avenue, New York, NY.
Elsevier launches Ebola Information Center with free clinical and research resources to support response to outbreak: 6/15/2026 10:54:14 AM; Following the World Health Organization’s declaration of an Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of Congo and Uganda as a Public Health Emergency of International Concern (PHEIC), Elsevier, a global leader in scientific information and analytics, has launched its Ebola Information Center to provide healthcare professionals, researchers, …
Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy: 6/15/2026 10:48:37 AM; Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in proteinuria vs placebo at 34 weeks If approved, Ultomiris would be the first C5 complement inhibitor available for this rare kidney disease Alexion, AstraZeneca Rare Disease’s supplemental Biologics License Application (sBLA) for …
Caring for non-communicable diseases during pregnancy, expert convening: 6/15/2026 10:36:28 AM; The World Health Organization (WHO) is developing new recommendations to improve care for pregnant and postpartum women living with noncommunicable diseases (NCDs).
“Beyond Feet on Fire” is Free to Download for Only Five Days (Until 6/19/26): 6/15/2026 6:00:00 AM; Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” It will be available in the Amazon store for free for only five days.
Bombardier Defense Expands Collaboration with Aero-Dienst/ADAC with a Second Challenger 650 Aircraft for Medevac: 6/12/2026 10:48:35 AM; • Bombardier Defense signs deal with German-based operator Aero-Dienst GmbH, a wholly owned subsidiary of ADAC SE, for a second Bombardier Challenger 650 aircraft that will be added to its medevac fleet • The Challenger 650 aircraft supports critical missions worldwide with proven reliability, long-range performance and cabin flexibility • Additional aircraft …
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients: 6/12/2026 10:38:47 AM; • Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery. • Cataracts are one of the leading causes of vision impairment.1 Nearly 20% of Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet only 5% have had cataract surgery.2 • Over half a million eyes worldwide …
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy: 6/10/2026 6:17:01 PM; Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped.
Huawei Launches the "AHEAD" Program to Build a New Ecosystem for Mutual Benefits in Education and Healthcare: 6/10/2026 6:10:47 PM; The 2026 Global Education & Healthcare Partners Convention, convened under the theme “Together, Enabling Intelligent-led Education & Healthcare,” successfully concluded in China.
Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO - May 2026: 6/10/2026 9:20:39 AM; At the mid-way point of Immunization Agenda 2030 (IA2030), countries gathering at the Seventy-ninth World Health Assembly (WHA79) marked an important moment in reaffirming their commitment to reaching everyone, everywhere with life-saving vaccines.
AMA adopts new policies to improve affordable access to obesity treatments: 6/9/2026 9:02:36 AM; Physicians and medical students convened for the Annual Meeting of the American Medical Association’s (AMA) House of Delegates today and adopted new policies aimed at improving patient access to evidence-based obesity treatments while advancing broader efforts to address prescription drug affordability and insurance coverage barriers.
Wiley Launches Advanced Brain to Push Disciplinary Boundaries Across Neuroscience & Related Fields: 6/9/2026 8:08:00 AM; Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of Advanced Brain, an open access, interdisciplinary journal dedicated to publishing cutting-edge research across neuroscience, neurology, psychiatry and psychology.
Mental health: although screens can play a negative role, more than 6 out of 10 people turn to artificial intelligence for psychological support: 6/8/2026 5:23:06 PM; • AXA and Ipsos have surveyed people in 18 countries about their mental health, which continues to decline. 46% of those surveyed say they are struggling or languishing.